Your browser doesn't support javascript.
loading
Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Report.
Uchida, Eriko; Komori, Kazutoshi; Kurata, Takashi; Taki, Masashi; Sakashita, Kazuo.
Affiliation
  • Uchida E; Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan.
  • Komori K; Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan.
  • Kurata T; Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan.
  • Taki M; Department of Pediatrics, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan.
  • Sakashita K; Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan, sakasita@shinshu-u.ac.jp.
Acta Haematol ; 144(3): 293-296, 2021.
Article in En | MEDLINE | ID: mdl-32702700
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Factor X / Factor VIIa / Hemophilia B / Blood Coagulation Factor Inhibitors / Hypersensitivity Type of study: Etiology_studies Limits: Humans / Infant / Male Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Factor X / Factor VIIa / Hemophilia B / Blood Coagulation Factor Inhibitors / Hypersensitivity Type of study: Etiology_studies Limits: Humans / Infant / Male Language: En Year: 2021 Type: Article